| Symbol | OCEAW |
|---|---|
| Name | OCEAN BIOMEDIACAL, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 02903 United States RI 55 Claverick St. Room 325 |
| Telephone | (401)444-7375 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | US |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;Expert Market |
| Auditor | MaloneBailey, LLP; |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001869974 |
| Description |
Ocean Biomedical Inc (OCEA) was removed from the list of traded instruments on NASDAQ exchange
Read moreNASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Ocean Biomedical, Inc. - Common Stock.
Read moreNASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Ocean Biomedical, Inc. - Common Stock.
Read moreNASDAQ symbol attribute type Security_Name was changed. Previous value: Ocean Biomedical, Inc. - Common Stock. New value: Ocean Biomedical, Inc. - Common Stock.
Read moreNASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.
Read moreNASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Ocean Biomedical, Inc. - Common Stock.
Read moreNASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Ocean Biomedical, Inc. - Common Stock.
Read moreNASDAQ traded attribute type Security_Name was changed. Previous value: Ocean Biomedical, Inc. - Common Stock. New value: Ocean Biomedical, Inc. - Common Stock.
Read moreNASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.
Read moreOcean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China
Read more